Shares of Abbott Laboratories (ABT) are falling about 4 percent on Thursday morning trading after the company announced a decline in first-quarter earnings to $1.07 billion, or $0.61 per share, from last year's $1.32 billion, or $0.76 per share.
The company's stock is currently trading at $97.21, down 4.21 percent or $4.27, over the previous close of $101.56 on the New York Stock Exchange. It has traded between $96.82 and $139.06 in the past one year.
However, the company's revenue for the period rose to $11.16 billion from $10.35 billion in the previous year. Additionally, the company stated that it now projects full-year 2026 adjusted EPS of $5.38 to $5.58.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.